Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TOM SAUERWEIN

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1265410567
CMS profile
1196795
Location
JBSA LACKLAND, TX

General Payments · PY2018–2020

$94,808.60

  • Reported across 132 records
  • CMS publication 2026-01-23

Latest program year · PY2020

$19,021.57

26 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2020 · sorted by reported total

By paying entity

PY2020 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $13,930.02 18
Merck Sharp & Dohme Corporation $5,091.55 8

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $22,721.49 35
PY2019 $53,065.54 71
PY2020 $19,021.57 26

Payment records · PY2020 (26)

Sorted by paying entity, then date · as published by CMS

Program year 2020 20182019 Record-level detail is published for PY2020; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $34.50 01/29/2020 Travel and Lodging Undisputed 01/23/2026 735996659 CMS
AstraZeneca Pharmaceuticals LP $2,700.00 02/09/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 736105059 CMS
AstraZeneca Pharmaceuticals LP $47.90 03/06/2020 Food and Beverage Undisputed 01/23/2026 735769333 CMS
AstraZeneca Pharmaceuticals LP $104.71 03/06/2020 Food and Beverage Undisputed 01/23/2026 735778869 CMS
AstraZeneca Pharmaceuticals LP $595.01 03/06/2020 Travel and Lodging Undisputed 01/23/2026 735794203 CMS
AstraZeneca Pharmaceuticals LP $18.56 03/06/2020 Travel and Lodging Undisputed 01/23/2026 735850369 CMS
AstraZeneca Pharmaceuticals LP $292.50 03/06/2020 Travel and Lodging Undisputed 01/23/2026 736068591 CMS
AstraZeneca Pharmaceuticals LP $15.40 03/06/2020 Food and Beverage Undisputed 01/23/2026 736172361 CMS
AstraZeneca Pharmaceuticals LP $39.38 03/06/2020 Food and Beverage Undisputed 01/23/2026 736250637 CMS
AstraZeneca Pharmaceuticals LP $34.43 03/06/2020 Food and Beverage Undisputed 01/23/2026 736338331 CMS
AstraZeneca Pharmaceuticals LP $5,350.00 03/19/2020 Consulting Fee Undisputed 01/23/2026 736440819 CMS
AstraZeneca Pharmaceuticals LP $800.00 03/22/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 735996837 CMS
AstraZeneca Pharmaceuticals LP $900.00 06/01/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 736302741 CMS
AstraZeneca Pharmaceuticals LP $250.00 06/04/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 736323767 CMS
AstraZeneca Pharmaceuticals LP $13.68 06/16/2020 Food and Beverage Undisputed 01/23/2026 735796817 CMS
AstraZeneca Pharmaceuticals LP $0.95 06/16/2020 Food and Beverage Undisputed 01/23/2026 736027445 CMS
AstraZeneca Pharmaceuticals LP $33.00 06/16/2020 Travel and Lodging Undisputed 01/23/2026 736198407 CMS
AstraZeneca Pharmaceuticals LP $2,700.00 06/30/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 736217737 CMS
Merck Sharp & Dohme Corporation $32.59 01/28/2020 Travel and Lodging Undisputed 01/23/2026 747657137 CMS
Merck Sharp & Dohme Corporation $17.32 01/28/2020 Food and Beverage Undisputed 01/23/2026 753388533 CMS
Merck Sharp & Dohme Corporation $89.05 01/29/2020 Food and Beverage Undisputed 01/23/2026 747643421 CMS
Merck Sharp & Dohme Corporation $32.59 01/29/2020 Travel and Lodging Undisputed 01/23/2026 747643451 CMS
Merck Sharp & Dohme Corporation $150.00 02/29/2020 Travel and Lodging Undisputed 01/23/2026 747643453 CMS
Merck Sharp & Dohme Corporation $150.00 02/29/2020 Travel and Lodging Undisputed 01/23/2026 747657139 CMS
Merck Sharp & Dohme Corporation $2,310.00 03/18/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 747643473 CMS
Merck Sharp & Dohme Corporation $2,310.00 03/18/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 747657141 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020
Generated from
OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.